English · Not set Change ▾

Language Location Show all languages

Live scores ticker: On · Turn off

Markets ticker: Off · Turn on

Saved in a cookie on this device (and in your account when you are logged in). We never store your IP address.

Entities › name

RNAi

4 headlines · 2 outlets · 2026-10-06 → 2026-10-16 · Wikipedia ↗ · 🔒 Follow

Latest coverage

bioRxiv ·Oct 16, 2026 ☆

University / research
Country: United States

Lipid nanoparticle-mediated RNAi targeting of KRAS mutants sensitises colorectal cancer cells to chemotherapy

KRAS mutations, including G12D, G12V and G13D, are major oncogenic drivers in colorectal cancer (CRC) and are associated with therapeutic resistance. However, approved KRAS inhibitors remain focused on G12C subtype, leaving these prevalent variants without approved targeted therapies. Here, we…

Health Science Details Archived copy ↗

PR Newswire: Health ·Oct 13, 2026 ☆

Press releases
Country: United States

Rona Therapeutics enters into global license agreement with Roche for ALK7-targeting RNAi therapy for obesity and metabolic diseases

SANTA BARBARA, Calif., Oct. 13, 2026 /PRNewswire/ -- Rona Therapeutics today announced it has granted Roche (SIX: RO, ROG; OTCQX: RHHBY) an exclusive worldwide license for Rona's investigational RNAi candidate targeting activin receptor-like kinase 7 (ALK7) utilizing the company's...

Health Details Archived copy ↗

RNAi

Latest coverage

Lipid nanoparticle-mediated RNAi targeting of KRAS mutants sensitises colorectal cancer cells to chemotherapy

Rona Therapeutics enters into global license agreement with Roche for ALK7-targeting RNAi therapy for obesity and metabolic diseases

Explore

News

Daily

Watch & listen

Sports

Local & weather

Understand & explore

Join

Banana News

Upgrade to unlock this

Keyboard shortcuts

Move

Go

Everywhere

Ask Ara